Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor‐2) to accelerate wound healing in venous ulcers
暂无分享,去创建一个
L C Parish | D. Steed | M. Robson | D. Odenheimer | V. Falanga | T. Phillips | L. Parish | T J Phillips | V Falanga | D L Steed | M C Robson | J. Jensen | D J Odenheimer | J L Jensen | David L. Steed
[1] D. Clement,et al. Venous Ulcer Reappraisal: Insights from an International Task Force , 1999, Journal of Vascular Research.
[2] グルーバー,ヨアヒム・エル,et al. Keratinocyte growth factor-2 , 1995 .
[3] D. Birnbaum,et al. Structure and Expression of Human Fibroblast Growth Factor-10* , 1997, The Journal of Biological Chemistry.
[4] M. Robson. Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .
[5] Trevor A Sheldon,et al. A systematic review of compression treatment for venous leg ulcers , 1997, BMJ.
[6] S. Aaronson,et al. Characterization of Recombinant Human Fibroblast Growth Factor (FGF)-10 Reveals Functional Similarities with Keratinocyte Growth Factor (FGF-7)* , 1998, The Journal of Biological Chemistry.
[7] W. Payne,et al. Maintenance of wound bacterial balance. , 1999, American journal of surgery.
[8] N. Itoh,et al. Cloning of mouse FGF10 and up-regulation of its gene expression during wound healing. , 1997, Gene.
[9] J J Dale,et al. Chronic ulcer of the leg: clinical history. , 1987, British medical journal.
[10] M. Robson,et al. In vivo characterization of keratinocyte growth factor‐2 as a potential wound healing agent , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[11] D. Margolis,et al. Management of chronic venous leg ulcers: a literature-guided approach. , 1994, Clinics in dermatology.